<div class="white-sheet">
	<div class="content-slide">

		<div class="title-bar red"></div>

		<div class="wrapper slide-2-4-1">

			<div class="popups" style="position:absolute">
				<div data-effect="fade" data-duration="1000" data-target="references-overlay" data-width="600" data-height="490" class="references-button show-overlay"></div>			
				<div data-effect="fade" data-duration="1000" data-target="information-overlay" data-width="600" data-height="490" class="information-button show-overlay"></div>	
			</div>

			<div class="slide-title red">
				Diagnosis of acquired aplastic anaemia: overview
			</div>


			<div class="content-container">

					<ul>
						<li><span>All new patients presenting with acquired aplastic anaemia should be assessed to:<sup>1</sup></span>
							<ul>
								<li><span>Confirm the diagnosis and exclude other causes of pancytopenia and hypocellular bone marrow</span></li>
								<li><span>Classify disease severity using the blood and bone marrow criteria</span></li>
								<li><span>Document the presence of associated paroxysmal nocturnal haemoglobinuria (PNH) and cytogenetic clones</span></li>
								<li><span>Exclude late-onset inherited bone marrow failure syndromes</span></li>
							</ul>
						</li>
						<li><span>Despite the precision of the diagnostic criteria for acquired aplastic anaemia, it is still a diagnosis of exclusion<sup>2</sup></span></li>
						<li><span>In some patients, blood count may remain stable for years and patients may be asymptomatic<sup>3</sup></span>
							<ul>
								<li><span>Moderate aplastic anaemia may not require treatment<sup>4</sup></span></li>
							</ul>
						</li>
						<li><span>Patients commonly seek medical attention and a diagnosis when they experience symptoms of anaemia or bleeding, by which time pancytopenia and HSC deficiency has worsened<sup>4</sup></span></li>
					</ul>

			</div>

		</div>

		<div class="information-overlay overlay">
			
			<header>Diagnosis of acquired aplastic anaemia: overview</header>
			
			<ul>
				<li><span>Distinction between acquired aplastic anaemia and other disorders such as MDS can be challenging, particularly in older patients<sup>3</sup></span></li>
				<li><span>Patients commonly seek medical attention and a diagnosis when they experience symptoms of anaemia or bleeding, by which time pancytopenia and HSC deficiency has worsened<sup>4</sup></span>
					<ul>
						<li><span>Severe aplastic anaemia almost always requires treatment<sup>4</sup></span></li>
					</ul>
				</li>
				<li><span>Patient outcome is related to the time from diagnosis to treatment<sup>2</sup></span></li>
			</ul>

		</div>


		<div class="references-overlay overlay">

			<header>References</header>
				
			<ul>
				<li class="navigateHref" data-navtarget="media/documents/BolonB-2012-ToxicolPathol-v40p216.pdf"><span>Marsh JCW <i>et al. Br J Haematol</i> 2009;147:43</span></li>
				<li class="navigateHref" data-navtarget="media/documents/BolonB-2012-ToxicolPathol-v40p216.pdf"><span>Guinan EC. <i>Hematology Am Soc Hematol Educ Program</i> 2011:76 </span></li>
				<li class="navigateHref" data-navtarget="media/documents/BolonB-2012-ToxicolPathol-v40p216.pdf"><span>Brodsky RA & Jones RJ. <i>Lancet</i> 2005;365:1647</span></li>
				<li class="navigateHref" data-navtarget="media/documents/BolonB-2012-ToxicolPathol-v40p216.pdf"><span>Scheinberg P & Young NS. <i>Blood</i> 2012;120:1185</span></li>
			</ul>

		</div>

	</div>
</div>